Format

Send to

Choose Destination
Int J Cardiol. 2013 Aug 20;167(4):1109-17. doi: 10.1016/j.ijcard.2012.09.085. Epub 2012 Nov 9.

Non-alcoholic fatty liver disease and cardiovascular risk.

Author information

1
Unidad de Lípidos, Servicio de Medicina Interna, Hospital San Pedro, Logroño, Spain.

Abstract

The term "Non-alcoholic fatty liver disease" (NAFLD) covers a series of liver lesions similar to those induced by alcohol, but not caused by alcohol use. The importance of NAFLD lies in the high prevalence in Western societies and, from the point of view of the liver, in its progression from steatosis to cirrhosis and liver cancer. More recently, NAFLD has been found to be associated with lipid metabolism disorders, the deposition of fat outside of the adipocytes, insulin resistance and Metabolic Syndrome. Also attributed to NAFLD is a heightened systemic pro-inflammatory state, which accelerates arteriosclerosis, thereby increasing cardiovascular risk and associated cardiovascular events. Here we provide an update to the etiopathogenesis of NAFLD, its influence on cardiovascular disease, and the treatment options.

KEYWORDS:

Alcohol; Cardiovascular disease; Fatty liver; Non-alcoholic fatty liver disease

PMID:
23141876
DOI:
10.1016/j.ijcard.2012.09.085
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center